The Efficacy and Safety of Temozolomide in Patients With MPPGL

Clinical trial NCT05858177 · COMPLETED

Trial details

NCT number: NCT05858177
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pheochromocytoma, Metastatic Paraganglioma, Malignant Pheochromocytoma Malignant

Start date: 2019-10-01
Primary completion: 2022-10-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.